Últimas notícias Butantan Institute

Chegada de 59.800 doses da vacina CoronaVac (17.03.2021)
Foto: Breno Esaki/Agência Saúde DF
Health

Institute requestes recommendation to vaccinate children aged 3 to 5

In case the request is granted by Brazil’s drug regulator Anvisa, Coronavac may be the first vaccine against coronavirus authorized for children from 3 years onwards.

 

Fachada do centro de pesquisa biológica Instituto Butantan
Health

Single vaccine against COVID-19 and influenza has promising results

The vaccine includes ButanVac - an immunizer produced by Butantan, which is being evaluated in clinical trials, and the influenza vaccine, also produced by the institute.

Chegada de 59.800 doses da vacina CoronaVac (17.03.2021)
Foto: Breno Esaki/Agência Saúde DF
Health

Butantan study shows higher efficiency of CoronaVac

Study found 99% of vaccinated people in Serrana seroconverted.The indicator was higher than the results from the clinical trials from phases one and two of CoronaVac, showing seroconversion at around 97 and 98 percent, respectively, depending on the dose.

Chegada de 59.800 doses da vacina CoronaVac (17.03.2021)
Foto: Breno Esaki/Agência Saúde DF
Fachada,Instituto Butantan
Health

Butantan Institute starts producing its vaccine against COVID-19

ButanVac will be produced at the Butantan factory where flu vaccines are made—a production that has already come to an end this year. ButanVac will be fully manufactured in São Paulo, with no imported supplies necessary.